M.D.A will continue distribution of fast test kits - Troubling Infection coefficient index: 1.14

wwwww

by Ifi Reporter Category:Health Sep 17, 2021

Magen David Adom will continue today with the distribution of fast test kits. Magen David Adom, the Ministries of Education and Health and the local government will distribute antigen test kits today and Sunday, as part of preparations for returning to school after the Sukkot holiday. The test kits are designed for children aged two years and nine months to twelve and thirteen months, and they will be distributed in educational institutions and complexes for rapid tests up to twenty-nine months a month. It is recommended to coordinate the receipt of assessments on the MDA website.
Meanwhile, Magen David Adom will also launch the rapid testing system this weekend. The members of the organization will be deployed in one hundred and ninety rapid inspection posts throughout the country, including check-in and travel complexes.
Two planes landed in Israel this morning, including hundreds of thousands of rapid test kits for Abbott's Corona. Another plane is expected to land today. In the last few days, about twenty flights have landed in Israel and they will continue to land in Israel next week. The intention is to bring about two million rapid test kits to Israel. 

The Ministry of Health updated the corona data in Israel, with the end of the Yom Kippur fast. According to the new data, 8,586 new positives were diagnosed in Corona on Wednesday and now the number of active patients in Israel stands at 83,652 patients.
The percentage of positive tests yesterday was 5.93% and the coefficient of infection is 1.14. The number of severe patients is 654 patients, of whom 237 are defined as critical and 186 are respiratory. The number of deaths from the plague also increased during the holiday and now stands at 7,465. The fight against the plague continues all the time and according to the latest data, the number of vaccinated in the third dose is approaching three million, with 2,984,406 Israelis already receiving the third dose. The number of vaccinated in the second dose is 5,566,238, while 6,056,243 received the first vaccine dose. 
In another matter, the third dose of the corona virus vaccines tenfold improves protection against infection and serious illness, according to a study published today (Thursday) in the New England Journal of Medicine. The study, which addresses the Booster dose of the pharmaceutical company Pfizer, indicates a significant increase in protection compared to those who were vaccinated with only two doses, and it has been five months or more since he received the second dose.
The study was conducted by a team of researchers from the Weizmann Institute of Science, the Ministry of Health, the Technion, the Hebrew University, the Gartner Institute at Sheba Medical Center and the KI Institute. As part of this, more than one million Israelis were divided into two groups who were entitled to the booster dose from the start of the vaccination campaign. The first group included those who had not yet been vaccinated in the booster dose, and the second group who had been vaccinated and were referred to as the "booster group".
The researchers found that 12 days after receiving the booster dose, the verified rate and the severity of patients were ten times smaller in the booster group compared to the first group, of those not yet vaccinated in the third dose. Even by more conservative analysis, which attempted to neutralize possible behavioral differences between the two groups, the verified rate was five times smaller in the booster group.
Naturally, the research groups changed during it, as people who were first included in the first group were vaccinated, and became part of the booster group. In total, in the group that did not receive the booster dose, 4,439 verified and 294 critically ill patients were registered - compared with 934 verified and 29 critically ill patients in the booster group.
To achieve a high level of confidence in the results, the research team analyzed the data using several statistical models, trying to neutralize as much as possible different intervening variables, including behavioral differences and differences in individual characteristics between the groups.
Bottom line, the study indicates a high dose-boosting effect in preventing infection and preventing serious illness. In fact, if the chance of being vaccinated against the Delta is currently about half that of the unvaccinated, as evidenced by various studies, the booster dose lowers this relative chance to 5%. In other words, a third dose of Pfizer vaccines returns the immune protection to a level of about 95% - similar to the original protection of a "fresh" vaccine that was observed against the less contagious alpha strain. Future studies could determine the long-term efficacy of a third dose of the vaccine against Delta and against future variants.

444 Views

Comments

No comments have been left here yet. Be the first who will do it.
Safety

captchaPlease input letters you see on the image.
Click on image to redraw.

ABOUT IFI TODAY

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum

Testimonials

No testimonials. Click here to add your testimonials.